Less than a third of heavily advertised drugs have 'high therapeutic value': study
Television ads for drugs are filled with glowing images of people living their best lives, all thanks to that new med they've been prescribed.
Jan 19, 2023
1
73
Television ads for drugs are filled with glowing images of people living their best lives, all thanks to that new med they've been prescribed.
Jan 19, 2023
1
73
Bone loss is a part of aging that compromises quality of life and movement in many older people, but regenerative treatments to improve their health and well-being have been limited. Now, a study led by Lankenau Institute ...
Jan 19, 2023
0
64
In research published in Nature Medicine today, AI biotech company Owkin has demonstrated for the first time that federated learning (FL) can be used to train deep learning models on data from multiple hospitals on histopathology ...
Jan 19, 2023
0
4
For generations people have associated the terms "lab rat" and "guinea pig" with scientific research. Animal testing remains a standard and has been required for drug approval.
Jan 16, 2023
0
55
Technological advances in the first two decades of the 21st century have profoundly impacted medical research in many ways, with large population cohorts, biological sample collections and datasets through biobanks becoming ...
Jan 9, 2023
0
2
Collaborative research between University of Galway and Brunel University London has found that patients with severe and complicated obesity respond differently to a dietary weight loss program based on their genes.
Jan 5, 2023
0
2
Dr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University Hospital Bonn (UKB), is investigating which patients with metastatic bladder cancer ...
Dec 30, 2022
0
17
Using the CRISPR-Cas9 gene editing system, UT Southwestern researchers corrected mutations responsible for a common inherited heart condition called dilated cardiomyopathy (DCM) in human cells and a mouse model of the disease. ...
Dec 21, 2022
0
72
Compared to men, we know much less about how women experience disease.
Dec 12, 2022
0
1064
Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole ...
Dec 7, 2022
0
2